More companies in the pharmaceutical industry than any other
industry are set to increase their reliance on information
technology (IT) and business process (BP) outsourcing this year,
new research indicates.
The Chinese government has announced plans to consolidate their
outsourcing industry in an effort to capture business from other
developing countries such as India.
The contract packaging biz is moving from an ad-hoc to a more
strategically determined, long-term approach, as pharma companies
begin to relax in the arms of service providers.
According to a new report, pharmaceutical and biotech companies
have not fully exploited the potential outsourcing represents,
having only been adopted to a limited extent to date by companies.
Most drug companies are not planning to increase the level of sales
and marketing IT they outsource over the next 3-5 years - a sign
that this niche segment may be bucking the wider pharmaceutical
industry outsourcing trend.
Capgemini has received a new five year outsourcing contract to
provide IT services to ensure the smooth sailing of pharmaceutical
company Astellas US, newly-formed after a recent merger.
To increase the chance of success in IT outsourcing, companies must
increase their focus on creating and managing a successful mixture
of supplier relationships that work for them.
As the outsourcing craze continues to sweep the pharma industry,
those participating should learn the secrets to establishing and
managing successful outsourcing relationships and be aware of the
key legal issues. A new guide to pharma...
If you're a big pharma company, outsourcing the writing of medical
publications is not the way to go, according to a report by
pharmaceutical business intelligence firm Cutting Edge Information.
Indian IT company Tata Consultancy Services (TCS) has scored a
contract from Danish pharma company Novo Nordisk for the data
management of its clinical trials run in India.
PDI, who provides sales and marketing services to the
pharmaceutical industry, have received a new sales representative
contract in the US from GlaxoSmithKline (GSK), worth $65-70m
(€55-59m).
Shanghai-based biotech company WuXi PharmaTech has grown more than
100 times in the last 5 years after operating successfully in
China's infant biotech industry by providing variety of outsourcing
services in drug R&D.
Affiliated Computer Services (ACS), announced today that it has
been awarded an additional information technology (IT) outsourcing
contract with GlaxoSmithKline (GSK), valued at $100.5 million (€82
million) over five years.
